Merck to Pay $4.85 Billion to VIOXX Claimants
Merck & Co, a pharmaceutical sales company, plans to offer $4.85 billion to plaintiffs in pending injury cases involving complications from VIOXX.
Original post by Total Injury
Merck & Co, a pharmaceutical sales company, plans to offer $4.85 billion to plaintiffs in pending injury cases involving complications from VIOXX.
Original post by Total Injury